FDA Corrects Final Rule for Professional Labeling of Aspirin and Antacid Products

Summary

The Food and Drug Administration (FDA) is correcting a final rule published on October 23, 1998, due to inadvertent editorial errors in the document that provided professional labeling for over-the-counter internal analgesic, antipyretic, and antirheumatic drug products containing aspirin, buffered aspirin, and aspirin in combination with an antacid.